Barclays Maintains Overweight on Amdocs, Raises Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Tavy Rosner maintains an Overweight rating on Amdocs (NASDAQ:DOX) and raises the price target from $105 to $115, indicating a positive outlook on the company's stock.
February 08, 2024 | 7:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Overweight rating on Amdocs and raises the price target to $115, signaling confidence in the company's future performance.
The upgrade in the price target by a reputable analyst like Tavy Rosner from Barclays indicates a strong belief in Amdocs' potential for growth and profitability. This is likely to instill confidence in investors and could lead to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100